HealthEquity, Inc. filed its Form 10-Q for the quarterly period ended July 31, 2026, reporting net income of $65.6 million for the three months ended July 31, 2026, and $135.1 million for the six months ended July 31, 2026.
Key Highlights
- Total revenue (Q2): $350.7 million for the three months ended July 31, 2026, up from $325.8 million in the same period of the prior year, according to the filing.
- Net income (Q2): $65.6 million for the three months ended July 31, 2026, compared to $59.9 million in the prior-year quarter.
- Diluted EPS (Q2): $0.78 per share for the three months ended July 31, 2026, versus $0.68 in the prior-year quarter.
- Six-month total revenue: $705.4 million for the six months ended July 31, 2026, compared to $656.7 million in the prior-year period.
- Share count: As of August 20, 2026, the filing disclosed 82,715,296 shares of common stock outstanding.
- Common shares repurchased: The company reported $231.1 million in total repurchases charged against additional paid-in capital and accumulated earnings for the six months ended July 31, 2026 (combining $62.8 million and $168.4 million, respectively).
- Total assets: $3.271 billion as of July 31, 2026, compared to $3.380 billion as of January 31, 2026.
HealthEquity Q2 Fiscal 2027: Revenue Growth and Earnings Detail
According to the 10-Q filed with the SEC for the quarterly period ended July 31, 2026, HealthEquity, Inc. (NASDAQ:HQY) reported total revenue of $350.7 million for the three months ended July 31, 2026. The filing breaks this into three streams: service revenue of $124.4 million, custodial revenue of $175.9 million, and interchange revenue of $50.4 million. For the comparable prior-year quarter, those figures were $117.9 million, $159.9 million, and $48.1 million, respectively. Gross profit for the second quarter was $258.0 million, up from $232.6 million in the prior-year period, the filing disclosed.
For the six months ended July 31, 2026, the registrant reported total revenue of $705.4 million and net income of $135.1 million, compared to $656.7 million in revenue and $113.8 million in net income for the six months ended July 31, 2025. Income from operations reached $201.6 million for the six-month period, versus $172.7 million in the prior-year period, according to the filing. Interest expense declined to $25.2 million for the six months ended July 31, 2026, from $29.8 million in the same prior-year period.
The condensed consolidated balance sheet as of July 31, 2026, showed total assets of $3.271 billion, with goodwill of $1.648 billion and intangible assets, net, of $1.048 billion. Long-term debt, net of issuance costs, stood at $931.1 million. Total stockholders' equity was $1.990 billion as of July 31, 2026, compared to $2.107 billion as of January 31, 2026. The filing noted accumulated other comprehensive loss of $69.1 million as of July 31, 2026, reflecting net unrealized losses on cash flow hedges of $63.2 million for the six-month period, net of income tax benefit of $20.6 million.
What Was Disclosed
HealthEquity's 10-Q for the period ended July 31, 2026, disclosed quarterly and six-month revenue, net income, earnings per share, balance sheet data, and stockholders' equity activity, including share repurchases and cash flow hedge losses recorded in other comprehensive loss.



Please wait processing your request...